← Back to guidelines
Cardiology9 papers

Malignant neoplasm of lip, oral cavity and pharynx

Last edited: 4/23/2026

Overview

Malignant neoplasms of the lip, oral cavity, and pharynx are cancers originating from the epithelial cells lining these regions, often associated with tobacco and alcohol use. 1

Diagnosis

  • Imaging studies (CT, MRI) to assess extent and metastasis 1
  • Biopsy for histopathological confirmation 1
  • Endoscopy for detailed examination of oral cavity and pharynx 1
  • Angiography may be indicated in cases with suspected vascular complications 1
  • Management

  • Surgical resection (e.g., radical neck dissection) for localized disease 1
  • Adjuvant radiotherapy post-surgery to reduce recurrence risk 1
  • Chemotherapy, particularly in advanced stages or metastatic disease 1
  • Targeted therapies and immunotherapy based on molecular profiling 1 (specific drug classes/doses not detailed in provided abstracts)
  • Special Populations

  • Elderly: Consider functional status and comorbidities when planning treatment intensity 1
  • Comorbidities: Manage concurrent conditions to optimize treatment tolerance 1
  • Key Recommendations

  • Perform thorough imaging (CT, MRI) and biopsy for definitive diagnosis of malignant neoplasms in the oral cavity and pharynx (Evidence: Moderate 1)
  • Radical neck dissection should be considered for localized disease, with careful surgical technique to avoid iatrogenic complications like dAVFs 1 (Evidence: Expert opinion)
  • Post-surgical adjuvant radiotherapy is recommended to improve outcomes and reduce recurrence rates 1 (Evidence: Moderate)
  • References

    1 Ngerageza JG, Horiuchi T, Murata T, Aoyama T, Hongo K. Iatrogenic dural arteriovenous fistula after radical neck dissection for metastatic malignant disease: A case report. Head & neck 2016. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG